Skip to main content

A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemia.

Author
Abstract
:

Iron deficiency anaemia is common in patients with non-dialysis-dependent chronic kidney disease (NDD-CKD) and is often treated with oral or intravenous (IV) iron therapy. This trial compared the efficacy and safety of IV iron isomaltoside 1000 (MonoferĀ®) and oral iron in NDD-CKD patients with renal-related anaemia.

Year of Publication
:
2016
Journal
:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Volume
:
31
Issue
:
4
Number of Pages
:
646-55
ISSN Number
:
0931-0509
URL
:
https://academic.oup.com/ndt/article-lookup/doi/10.1093/ndt/gfv293
DOI
:
10.1093/ndt/gfv293
Short Title
:
Nephrol Dial Transplant
Download citation